ISMPP announces opening of registration for 6th annual meeting on medical publications

NewsGuard 100/100 Score

The International Society for Medical Publication Professionals (ISMPP) is pleased to announce the opening of registration for its 6th annual meeting, "Delivering Value and Driving Advocacy in Medical Publications." The meeting will run from April 19 to 21, 2010, in Arlington, VA, at the Crystal Gateway Marriott.

ISMPP has created an exciting program that focuses on two of the most critical factors that are relevant to all who work in medical publications -- value and advocacy. Both are integral to ensuring that medical publication professionals can continue to contribute to the dissemination of the results of clinical trials with accuracy, transparency, and integrity.

To address these issues, this year's plenary sessions will explore such topics as the impact of guidelines and regulations, including GPP-2; ISMPP's advocacy activities; and insights of journal editors. Unique this year to the journal editors' segment is the rollout of an authors' tool kit that has been developed by editors of top-tier medical journals. As in the past, the meeting will also offer half-day pre- and post-conference workshops and original ISMPP member research presentations.

As Al Weigel, President of ISMPP, noted, "This meeting will not only build on previous conferences, but will also include insights for attendees on how ISMPP and medical publication professionals can help shape their own future by taking a more active role in driving advocacy in their activities."

ISMPP is proud to announce an outstanding group of renowned experts who will present Keynote Addresses on important aspects of medical publications:

  • Mark B. McClellan, MD, PhD (Former US FDA Commissioner and Administrator for the Centers of Medicaid and Medicare Services, and Director, Engelberg Center for Health Care Reform, The Brookings Institution): Defining Value in Healthcare and Medical Research

  • David Verbraska (Vice President, Pfizer, Inc., and Regulatory Policy and Technical Standards Committee Member, International Federation of Pharmaceutical Manufacturers & Associations): Industry Transparency in Posting and Publishing Clinical Trial Results

  • Stephanie Vance (The Advocacy Guru, Advocacy Associates, LLC): Delivering Value and Driving Advocacy in Medical Publications

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis